Historical record - last NADAC effective date: 10/10/2018
Product Information
TIMOPTIC-XE 0.5% GEL-SOLUTION is a brand product labeled by Bausch & Lomb Incorporated, priced at $40.0881 per ML under NDC 24208081605. Its NADAC has been published 15 times since Oct 10, 2018.
FDA first approved this application on Nov 4, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208081605
Classification
Brand
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
10/10/2018
Active Ingredients
TIMOLOL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA020330FDA Approved
11/4/1993
TE Code
AB
On Market Since
5/31/2016
Pharmacological Classes
Price Statistics
The NADAC for TIMOPTIC-XE 0.5% GEL-SOLUTION has been published 15 times since Oct 10, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $40.0881 per ML |
|---|---|
| All-time high | $40.0881 (Jan 16, 2019) |
| All-time low | $40.0881 (Oct 10, 2018) |
| Median price | $40.0881 |
| Average price | $40.0881 |
| Largest weekly change | 0.0% (Oct 17, 2018) |
| Weeks tracked | 15 |
| Tracking since | Oct 10, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIMOPTIC-XE 0.5% GEL-SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TIMOPTIC-XE 0.5% GEL-SOLUTION, manufactured by Bausch & Lomb Incorporated, is $40.0881 per ML (NDC 24208081605), effective Jan 16, 2019.
How has the price of TIMOPTIC-XE 0.5% GEL-SOLUTION changed over time?
Over the history we have for it, the NADAC for TIMOPTIC-XE 0.5% GEL-SOLUTION has held within roughly two percent of its current level. It has been tracked across 15 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for TIMOPTIC-XE 0.5% GEL-SOLUTION?
Since Oct 10, 2018, the NADAC for TIMOPTIC-XE 0.5% GEL-SOLUTION has ranged from a low of $40.0881 (Oct 10, 2018) to a high of $40.0881 (Jan 16, 2019), with a median of $40.0881 per ML.
Are there cheaper alternatives to TIMOPTIC-XE 0.5% GEL-SOLUTION?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.5% EYE DROPS, is $0.7316 per ML — about 98% below TIMOPTIC-XE 0.5% GEL-SOLUTION.
Who manufactures TIMOPTIC-XE 0.5% GEL-SOLUTION?
TIMOPTIC-XE 0.5% GEL-SOLUTION (NDC 24208081605) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.